Phase II Randomized Study: Whole Brain Radiotherapy and Concomitant Temozolomide, Compared With Whole Brain Radiotherapy for Brain Metastases Treatment.
Phase of Trial: Phase II
Latest Information Update: 07 May 2013
At a glance
- Drugs Temozolomide (Primary)
- Indications Brain metastases; Solid tumours
- Focus Therapeutic Use
- 06 Jun 2010 Results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
- 24 Nov 2009 New trial record